RADDoseDenseTherapyBrachytherapyNeoadjuvantTherapyCachexiaMastodyniaTripleNegativeBreastCancerCytostaticDoxorubicinNodeNegative1 in 8womenWomen ages40+ shouldhave a clinicalbreast examat least yearlyAntiemeticMethotrexateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearPhyllodesTumorEstradiolLCISACChemotherapyTriplePositiveBreastCancerTamoxifenTumorGradeGeneticPredispositionPaclitaxelER-MetastasisBreastTomosynthesisChemotherapyKappaEpsilonDocetaxelGuaranteedRenewableInsuranceDefinitiveSurgeryBI-RADSMastectomyHER-2SERMTyrosine-KinaseInhibitorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.NeoplasmNodePositiveAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBOCAAromataseInhibitorsCo-survivorMultifocalTumorsBilateralProphylacticMastectomyLumpDown-StagingAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCapecitabineFibroadenomaInvasiveBreastCancerRadiotherapyAnastrozoleFamilyHistoryCMFChemotherapyKi-67RateAdjuvantTherapyHerceptinCystLapatinibBRCAGeneAdenocarcinomaPhysicalactivity mayreduce therisk of breastcancersPalbociclibFISHMegestrolAcetateAntibodyTherapyRelapseHormoneReceptorStatusLumpectomyDimplingAngiogenesisCyclophosphamideCDK4/6InhibitorsPathologicResponsePrecisionMedicineBiopsyMultimodalityTherapyAyurveda5-FluorouracilmTORInhibitorsPalpationGenomicTestingStagingER+ECOGScoreGeneticCounselingBevacizumabMorpheaGeneMutationLymphNodeStatusMRIHormoneReplacementTherapyIn-situCarcinomaFlowCytometryPARPInhibitorsProgestinCheckpointInhibitorIntraductalPapillomaImmunotherapyRaloxifeneSelf-examinationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BreastCancerAxillarySamplingEGFR(epidermalgrowth factorreceptor)GailModelOvarianSuppressionAlopeciaLymphoscintigraphyOligometastasesAdvocacyCytotoxicPagetDiseaseEstrogenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPI3KinaseInhibitorsApoptosisChemopreventionExcisionalBiopsyGermlineMutationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AbsoluteRiskCAMCalcificationsRADDoseDenseTherapyBrachytherapyNeoadjuvantTherapyCachexiaMastodyniaTripleNegativeBreastCancerCytostaticDoxorubicinNodeNegative1 in 8womenWomen ages40+ shouldhave a clinicalbreast examat least yearlyAntiemeticMethotrexateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearPhyllodesTumorEstradiolLCISACChemotherapyTriplePositiveBreastCancerTamoxifenTumorGradeGeneticPredispositionPaclitaxelER-MetastasisBreastTomosynthesisChemotherapyKappaEpsilonDocetaxelGuaranteedRenewableInsuranceDefinitiveSurgeryBI-RADSMastectomyHER-2SERMTyrosine-KinaseInhibitorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.NeoplasmNodePositiveAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBOCAAromataseInhibitorsCo-survivorMultifocalTumorsBilateralProphylacticMastectomyLumpDown-StagingAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCapecitabineFibroadenomaInvasiveBreastCancerRadiotherapyAnastrozoleFamilyHistoryCMFChemotherapyKi-67RateAdjuvantTherapyHerceptinCystLapatinibBRCAGeneAdenocarcinomaPhysicalactivity mayreduce therisk of breastcancersPalbociclibFISHMegestrolAcetateAntibodyTherapyRelapseHormoneReceptorStatusLumpectomyDimplingAngiogenesisCyclophosphamideCDK4/6InhibitorsPathologicResponsePrecisionMedicineBiopsyMultimodalityTherapyAyurveda5-FluorouracilmTORInhibitorsPalpationGenomicTestingStagingER+ECOGScoreGeneticCounselingBevacizumabMorpheaGeneMutationLymphNodeStatusMRIHormoneReplacementTherapyIn-situCarcinomaFlowCytometryPARPInhibitorsProgestinCheckpointInhibitorIntraductalPapillomaImmunotherapyRaloxifeneSelf-examinationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.BreastCancerAxillarySamplingEGFR(epidermalgrowth factorreceptor)GailModelOvarianSuppressionAlopeciaLymphoscintigraphyOligometastasesAdvocacyCytotoxicPagetDiseaseEstrogenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPI3KinaseInhibitorsApoptosisChemopreventionExcisionalBiopsyGermlineMutationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AbsoluteRiskCAMCalcifications

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. RAD
  2. Dose Dense Therapy
  3. Brachytherapy
  4. Neoadjuvant Therapy
  5. Cachexia
  6. Mastodynia
  7. Triple Negative Breast Cancer
  8. Cytostatic
  9. Doxorubicin
  10. Node Negative
  11. 1 in 8 women
  12. Women ages 40+ should have a clinical breast exam at least yearly
  13. Antiemetic
  14. Methotrexate
  15. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  16. Phyllodes Tumor
  17. Estradiol
  18. LCIS
  19. AC Chemotherapy
  20. Triple Positive Breast Cancer
  21. Tamoxifen
  22. Tumor Grade
  23. Genetic Predisposition
  24. Paclitaxel
  25. ER-
  26. Metastasis
  27. Breast Tomosynthesis
  28. Chemotherapy
  29. Kappa Epsilon
  30. Docetaxel
  31. Guaranteed Renewable Insurance
  32. Definitive Surgery
  33. BI-RADS
  34. Mastectomy
  35. HER-2
  36. SERM
  37. Tyrosine-Kinase Inhibitor
  38. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  39. Neoplasm
  40. Node Positive
  41. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  42. BOCA
  43. Aromatase Inhibitors
  44. Co-survivor
  45. Multifocal Tumors
  46. Bilateral Prophylactic Mastectomy
  47. Lump
  48. Down-Staging
  49. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  50. Capecitabine
  51. Fibroadenoma
  52. Invasive Breast Cancer
  53. Radiotherapy
  54. Anastrozole
  55. Family History
  56. CMF Chemotherapy
  57. Ki-67 Rate
  58. Adjuvant Therapy
  59. Herceptin
  60. Cyst
  61. Lapatinib
  62. BRCA Gene
  63. Adenocarcinoma
  64. Physical activity may reduce the risk of breast cancers
  65. Palbociclib
  66. FISH
  67. Megestrol Acetate
  68. Antibody Therapy
  69. Relapse
  70. Hormone Receptor Status
  71. Lumpectomy
  72. Dimpling
  73. Angiogenesis
  74. Cyclophosphamide
  75. CDK4/6 Inhibitors
  76. Pathologic Response
  77. Precision Medicine
  78. Biopsy
  79. Multimodality Therapy
  80. Ayurveda
  81. 5-Fluorouracil
  82. mTOR Inhibitors
  83. Palpation
  84. Genomic Testing
  85. Staging
  86. ER+
  87. ECOG Score
  88. Genetic Counseling
  89. Bevacizumab
  90. Morphea
  91. Gene Mutation
  92. Lymph Node Status
  93. MRI
  94. Hormone Replacement Therapy
  95. In-situ Carcinoma
  96. Flow Cytometry
  97. PARP Inhibitors
  98. Progestin
  99. Checkpoint Inhibitor
  100. Intraductal Papilloma
  101. Immunotherapy
  102. Raloxifene
  103. Self-examination
  104. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  105. Breast Cancer
  106. Axillary Sampling
  107. EGFR (epidermal growth factor receptor)
  108. Gail Model
  109. Ovarian Suppression
  110. Alopecia
  111. Lymphoscintigraphy
  112. Oligometastases
  113. Advocacy
  114. Cytotoxic
  115. Paget Disease
  116. Estrogen
  117. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  118. PI3 Kinase Inhibitors
  119. Apoptosis
  120. Chemoprevention
  121. Excisional Biopsy
  122. Germline Mutation
  123. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  124. Absolute Risk
  125. CAM
  126. Calcifications